Teladoc Health reported a 41% year-over-year revenue increase to $180.8 million for Q1 2020. Total visits increased by 92% to 2.0 million. The company issued Q2 2020 guidance and updated full-year expectations.
Revenue grew 41% year-over-year to $180.8 million.
Total visits increased 92% year-over-year reaching 2.0 million.
Net loss was $(29.6) million compared to $(30.2) million in the first quarter 2019.
Adjusted EBITDA was $10.7 million compared to $1.2 million for the first quarter 2019.
Teladoc Health provides guidance based on current market conditions and expectations. For the second-quarter 2020, total revenue is expected to be in the range of $215 million to $225 million.
Analyze how earnings announcements historically affect stock price performance